Latest Cogstate (Asx:Cgs) News

Page 1 of 1
Cogstate Ltd reports a near doubling in sales contracts for the first half of 2026 but warns of timing-related revenue deferrals that will temper short-term earnings. Despite this, management remains optimistic about medium- and long-term growth prospects.
Ada Torres
Ada Torres
10 Dec 2025
Cogstate Limited reports a record-breaking quarter with sales contracts soaring 88% year-on-year, driven by expanding markets and new therapeutic areas. The company signals continued investment in growth initiatives, including AI and Asia-Pacific expansion, while projecting a strong first half of FY26.
Ada Torres
Ada Torres
16 Oct 2025
Cogstate Ltd has reported a strong FY25 with 22% revenue growth and a near doubling of profit before tax, declaring its first fully franked dividend and preparing to launch its inaugural AI-powered product in FY26.
Ada Torres
Ada Torres
22 Aug 2025
Cogstate Limited has reported a landmark FY25 with revenue up 22% and net profit before tax nearly doubling, driven by a surge in clinical trials contracts and strategic innovation. The company also declared its maiden fully franked dividend and outlined ambitious growth plans including AI product launches and an expanding Medidata partnership.
Ada Torres
Ada Torres
22 Aug 2025
Cogstate Limited reported a 22.3% rise in total revenue to US$53.1 million for FY25, driven by strong Clinical Trials growth, while profit before tax nearly doubled to US$13.9 million. The company also declared its inaugural fully franked dividend.
Ada Torres
Ada Torres
22 Aug 2025
Cogstate Ltd has upgraded its FY25 financial guidance, projecting a 20-24% revenue increase and nearly doubling profit before tax compared to last year.
Ada Torres
Ada Torres
24 June 2025